ReShape Lifesciences
Irvine · Founded 2002
About ReShape Lifesciences
ReShape Lifesciences is a weight-loss solutions company that offers an integrated portfolio of proven products and services that manage and treat obesity and metabolic diseases. The FDA-approved Lap-Band System provides minimally invasive, long-term treatment of obesity. It is an alternative to more invasive surgical stapling procedures such as gastric bypass or sleeve gastrectomy. The ReShape Vest System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy.
Company Facts
- Founded: 2002
- Operating status: Active
- Company type: For Profit
- IPO status: Delisted
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $194.4M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jun 2025)
- Ticker: otcqb:RSLS
- Website: https://www.reshapelifesciences.com/
- Phone: 844-937-7374
Industries & Categories
Biotechnology, Health Care, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/reshape-lifesciences-117158 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.